ASCOM HLDG NA SF 0,50
Ascom Holding AG, together with its subsidiaries, provides healthcare ICT and mobile workflow solutions worldwide. The company offers nurse call and monitoring systems, including teleCARE IP that provides wireless nurse call, alerts, messaging, monitoring, and wander management solution; and Telligence, a patient response system. It also provides Digistat, a suite of clinical workflow software; S… Read more
ASCOM HLDG NA SF 0,50 (AH2N) - Net Assets
Latest net assets as of June 2025: €72.20 Million EUR
Based on the latest financial reports, ASCOM HLDG NA SF 0,50 (AH2N) has net assets worth €72.20 Million EUR as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€190.50 Million) and total liabilities (€118.30 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €72.20 Million |
| % of Total Assets | 37.9% |
| Annual Growth Rate | -2.39% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 6.73 |
ASCOM HLDG NA SF 0,50 - Net Assets Trend (2021–2024)
This chart illustrates how ASCOM HLDG NA SF 0,50's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for ASCOM HLDG NA SF 0,50 (2021–2024)
The table below shows the annual net assets of ASCOM HLDG NA SF 0,50 from 2021 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €74.40 Million | -5.46% |
| 2023-12-31 | €78.70 Million | +7.22% |
| 2022-12-31 | €73.40 Million | -8.25% |
| 2021-12-31 | €80.00 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to ASCOM HLDG NA SF 0,50's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 9.3% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €69.50 Million | 93.41% |
| Other Components | €4.90 Million | 6.59% |
| Total Equity | €74.40 Million | 100.00% |
ASCOM HLDG NA SF 0,50 Competitors by Market Cap
The table below lists competitors of ASCOM HLDG NA SF 0,50 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
CoinShares
PINK:CSNRF
|
$190.68 Million |
|
First Western Financial Inc
NASDAQ:MYFW
|
$190.74 Million |
|
Siam City Cement Public Company Limited
PINK:SICUF
|
$190.83 Million |
|
Global PMX Co Ltd
TW:4551
|
$190.84 Million |
|
Forus S.A
SN:FORUS
|
$190.62 Million |
|
Shanghai Kaichuang Marine International Co Ltd
SHG:600097
|
$190.55 Million |
|
Karnell
ST:KARNEL-B
|
$190.51 Million |
|
Frontier Group Holdings Inc
NASDAQ:ULCC
|
$190.48 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ASCOM HLDG NA SF 0,50's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 78,700,000 to 74,400,000, a change of -4,300,000 (-5.5%).
- Net income of 3,700,000 contributed positively to equity growth.
- Dividend payments of 10,800,000 reduced retained earnings.
- Other factors increased equity by 2,800,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €3.70 Million | +4.97% |
| Dividends Paid | €10.80 Million | -14.52% |
| Other Changes | €2.80 Million | +3.76% |
| Total Change | €- | -5.46% |
Book Value vs Market Value Analysis
This analysis compares ASCOM HLDG NA SF 0,50's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.61x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 2.43x to 2.61x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | €2.22 | €5.41 | x |
| 2022-12-31 | €2.04 | €5.41 | x |
| 2023-12-31 | €2.19 | €5.41 | x |
| 2024-12-31 | €2.07 | €5.41 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently ASCOM HLDG NA SF 0,50 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 4.97%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.29%
- • Asset Turnover: 1.51x
- • Equity Multiplier: 2.55x
- Recent ROE (4.97%) is below the historical average (14.74%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | 16.88% | 4.63% | 1.50x | 2.43x | €5.50 Million |
| 2022 | 14.99% | 3.70% | 1.47x | 2.75x | €3.66 Million |
| 2023 | 22.11% | 5.85% | 1.51x | 2.51x | €9.53 Million |
| 2024 | 4.97% | 1.29% | 1.51x | 2.55x | €-3.74 Million |
Industry Comparison
This section compares ASCOM HLDG NA SF 0,50's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $1,999,249,851
- Average return on equity (ROE) among peers: -15.45%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ASCOM HLDG NA SF 0,50 (AH2N) | €72.20 Million | 16.88% | 1.64x | $190.62 Million |
| Schrödinger, Inc. (43Z) | $557.09 Million | -18.02% | 0.36x | $631.00 Million |
| DACHA STRATEGIC (7DC) | $40.24 Million | 0.65% | 0.08x | $81.97 Million |
| ABL Diagnostics Société anonyme (9BK0) | $6.77 Million | 0.80% | 1.20x | $371.65K |
| Zhejiang Taimei Medical Technology Co., Ltd. (A2V) | $1.04 Billion | -33.28% | 0.39x | $47.71 Million |
| DocCheck AG (AJ91) | $18.14 Million | 3.32% | 0.15x | $18.00 Million |
| EM Systems Co. Ltd (EMO) | $17.69 Billion | 7.87% | 0.33x | $74.55 Million |
| Tempus AI (F3M) | $-1.38 Billion | 0.00% | 0.00x | $4.75 Billion |
| Pangenomic Health Inc. (LL3) | $2.24 Million | -118.14% | 0.15x | $4.82 Million |
| MeVis Medical Solutions AG (M3V) | $17.83 Million | 17.76% | 0.45x | $12.89 Million |